A Brooklyn-based biotech company was awarded $32.3 million in incentives over 10 years from the state’s Economic Development Authority to move its headquarters to the 116-acre former Hoffmann-La Roche North American headquarters campus on the border of Nutley and Clifton.
OpGen announced today that it has priced a previously announced $10 million public offering of 25 million units of common stock and common warrants at $.40 per unit.
The US National Institutes of Health (NIH) would see its budget rise by US$1.1 billion in 2018, to $35.2 billion, under a spending proposal released on 12 July by lawmakers in the House of Representatives.
A new startup accelerator program based at the Johns Hopkins University’s FastForward East will target companies developing health and fitness technologies.
Hopkins is teaming up with the University of Maryland, Plank Industries, Brown Advisory and the Abell Foundation to launch the 16-week program, called M-1 Ventures, in September.
A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight cancer, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system to shut down the disease.
Who We Are
5 startups. 16 weeks. 1 mission.
M-1 Ventures is an accelerator for startups developing technologies that improve health outcomes, promote fitness and streamline health care. The program features mentorship from connected health and fitness experts at Johns Hopkins and the University of Maryland.
QIAGEN (Suzhou) Translational Medicine, a China precision medicine company, raised $25 million in a Series A funding led by Qiming Venture Partners. QIAGEN (Suzhou) was founded in 2013 by QIAGEN, a global molecular diagnostics company headquartered in Germany, and BioBay, the Suzhou life science technology park. It specializes in developing biomarkers and stratifying patients in clinical trials. QIAGEN (Suzhou) said it plans to use the new capital to build a factory and expand its scientific team.
Baltimore, Maryland-based Protenus, the company famously behind monthly Breach Barometers, is expanding its capabilities.
As part of a new effort, the organization will use its analytics platform to shed light on other problems in the world of healthcare. One example includes detecting suspected employee theft of prescription opiates.
The world’s top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers’ knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.
The 17th annual New York Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers.
Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, New York Venture Summit is one event you won’t want to miss.
